Several blood biomarkers such as platelet distribution width [23], coagulation biomarkers such as prothrombin and fibrinogen, as well as chemokines and anti-inflammatory cytokines have been correlated with COVID-19 severity in infected patients [24]. This evidence concerns the gene F2 and COVID-19.